Sanofi’s 6-in-1 paediatric shot Hexyon recommended for market approval

Sanofi Pasteur have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended market approval for their 6-in-1 paediatric vaccine Hexyon/Hexacima. The vaccine would be marketed as Hexyon in Western Europe, where it is a joint venture between Sanofi Pasteur and Merck & Co, and Hexacima in Eastern Europe, where it …